We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




AACC会议展示更好检测心脏病突发的新检验产品和新研究

By LabMedica International staff writers
Posted on 26 Oct 2015
Print article
图片A:i-Stat TOTAL ß-hCG——第一款且是唯一的一款手持式怀孕血检(图片取自雅培护理点i-Stat)。
图片A:i-Stat TOTAL ß-hCG——第一款且是唯一的一款手持式怀孕血检(图片取自雅培护理点i-Stat)。
图片B:Xprecia Stride凝集分析仪(图片蒙西门子医疗集团诊断部惠赐)。
图片B:Xprecia Stride凝集分析仪(图片蒙西门子医疗集团诊断部惠赐)。
7月26-30日于美国佐治亚州亚特兰大市举行的2015 AACC年会暨临床化验博览会是全球医疗化验专家的顶级盛会,展览的重点是更好地检测心脏病突发的新型临床检验产品和实时研究。还展示了更快、更简便检验的新型手持式技术。

本届会议举办了400多场培训会,主题涵盖个性化医疗、传染病、床旁检验和实验室自主开发检验等,还展示了200多种最新型的诊断产品。

除研讨会、全体会议、课程和展板外,AACC 2015大会还展示了史无前例的实时研究实验,该实验改进了识别心脏病突发及其未来发病风险的检验方法。这项突破性科学行动改进了心脏病突发的检验,与会者有机会参与其中并现场提供血样供研究。这项行动的目标是确立健康成人肌钙蛋白的基线值。这项研究有助于急诊室更快地区分心脏病突发与症状类似的其它病症,更好地识别心血管事件风险较高的病人。

展商展示了床旁诊断检验的最新产品以及更微创、更快、更便宜的检验产品。其中之一是雅培护理点i-STAT Total β-hCG,这是第一款且是唯一的一款手持式怀孕血检。研究显示,在怀孕的头几周,11种最流行的医院用怀孕尿检里有9种不可靠。在急诊场合,这项新血检对准确判定女性的怀孕状态发挥至关重要的作用,根据怀孕状态确定如何实施治疗,以免伤害婴儿。美国纽约州Tarrytown西门子医疗集团诊断部的Xprecia Stride凝集分析仪荣获2015年产品设计红点奖。这款手持式仪器第一次让医疗工作者能在门诊看病的过程中确定正在接受薄血疗法治疗以预防心脏病突发与脑卒中的患者是否处于不可控失血的风险。

AACC年会共持续了5天,与会者有机会学习一些令人兴奋的科学知识。全体会议上专家报告的主题有:血液中的肿瘤DNA诊断和监测癌症,减小心脏病风险,医疗服务的透明化,HIV治疗的最新进展,针对感染的新检验和新疗法。在AACC临床化验博览会上,700多家展商布满了佐治亚世界会议中心亚特兰大会展中心的展厅,展示的最新诊断技术包括移动医疗、分子诊断、质谱、护理点、自动化等等。

Related Links:
美国临床化学协会(AACC) 
AACC 2015年会暨临床化验博览会


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The real-time multiplex PCR test is set to revolutionize early sepsis detection (Photo courtesy of Shutterstock)

1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens

Sepsis contributes to one in every three hospital deaths in the US, and globally, septic shock carries a mortality rate of 30-40%. Diagnosing sepsis early is challenging due to its non-specific symptoms... Read more

Pathology

view channel
Image: The QIAseq xHYB Mycobacterium tuberculosis Panel uses next-generation sequencing (Photo courtesy of 123RF)

New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance

Tuberculosis (TB), the leading cause of death from an infectious disease globally, is a contagious bacterial infection that primarily spreads through the coughing of patients with active pulmonary TB.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.